Skip to Main Content

Paper Details

Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.
Mol Oncol
6
2022
Author NameAffiliation
Ronald de WitErasmus MC Cancer Institute
John W M MartensErasmus MC Cancer Institute
Martijn P LolkemaErasmus MC Cancer Institute
  • 1 - 3

Datasets

Release 1.2